No black box warning on record for Mylotarg

As of the latest FDA labeling reviewed, Mylotarg (GEMTUZUMAB OZOGAMICIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Mylotarg medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Infusion-related reactions (including anaphylaxis): Premedicate with a corticosteroid, acetaminophen, and diphenhydramine. Monitor patients during and for at least 1 hour after the end of the infusion. Interrupt the infusion, administer steroids or antihistamines, or permanently discontinue treatment as necessary ( 2.1 , 5.2 , 6 ). • Hemorrhage: Severe, including fatal

No black box warning on record for Mylotarg

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Infusion-related reactions (including anaphylaxis): Premedicate with a corticosteroid, acetaminophen, and diphenhydramine. Monitor patients during and for at least 1 hour after the end of the infusion. Interrupt the infusion, administer steroids or antihistamines, or permanently discontinue treatment as necessary ( 2.1 , 5.2 , 6 ). • Hemorrhage: Severe, including fatal

Mylotarg Black Box Warning

No black box warning on record for Mylotarg

Other warnings & precautions

Mylotarg Black Box Warning

No black box warning on record for Mylotarg

Other warnings & precautions